![Page 1: UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients 16 years old in 2013](https://reader035.vdocument.in/reader035/viewer/2022070610/5a4d1bb17f8b9ab0599ccd5b/html5/thumbnails/1.jpg)
UK Renal Registry 17th Annual Report
Figure 4.1. RRT treatment used by prevalent paediatric patients <16 years old in 2013
![Page 2: UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients 16 years old in 2013](https://reader035.vdocument.in/reader035/viewer/2022070610/5a4d1bb17f8b9ab0599ccd5b/html5/thumbnails/2.jpg)
UK Renal Registry 17th Annual Report
Figure 4.2. Treatment modality at start of RRT in prevalentpaediatric patients <16 years old in 2013
![Page 3: UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients 16 years old in 2013](https://reader035.vdocument.in/reader035/viewer/2022070610/5a4d1bb17f8b9ab0599ccd5b/html5/thumbnails/3.jpg)
UK Renal Registry 17th Annual Report
Figure 4.3. Primary renal disease percentage in incident andprevalent paediatric ERF patients <16 years old in 2013 for
whom a causative diagnosis was reported
![Page 4: UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients 16 years old in 2013](https://reader035.vdocument.in/reader035/viewer/2022070610/5a4d1bb17f8b9ab0599ccd5b/html5/thumbnails/4.jpg)
UK Renal Registry 17th Annual Report
Figure 4.4. Treatment modality at start of RRT for incident paediatric patients <16 years old by 5-year time period
![Page 5: UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients 16 years old in 2013](https://reader035.vdocument.in/reader035/viewer/2022070610/5a4d1bb17f8b9ab0599ccd5b/html5/thumbnails/5.jpg)
UK Renal Registry 17th Annual Report
Figure 4.5. Unadjusted KM survival in paediatric patients <16 years old starting RRT between 1999 and 2012, by age at start